Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
Status:
Recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of
alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables.
Burning mouth syndrome (BMS) is defined as an oral burning sensation in the absence of
clinical signs which could justify the syndrome.
Recent studies suggest the existence of neurological factors as a possible cause of the
disease.